Maternal serum biomarkers for risk assessment in gestational diabetes. A potential universal screening test to predict GDM status

Indian Journal of Endocrinology and Metabolism

Volumn 19, Issue 1, 2015, Pages 155-159

  Nagalla, Srinivasa R ^a   Snyder, Caryn K ^a   Michaels, John E ^a   Laughlin, Mary J ^a   Roberts, Charles T ^b   Balaji, Madhuri ^c   Balaji, V ^c   Seshiah, V ^c   Rao, Paturi V ^d  

^a DiabetOmics LLC   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Dr V Seshiah Diabetes Care and Research Institute   (India)

^d NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Gestational diabetes; glycosylated fibronectin; maternal serum biomarker

Indexed keywords

EID: 84981164530     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.140226     Document Type: Article

References (27)

1. Smyth S, Heron A. Diabetes and obesity: The twin epidemics. Nat Med 2005;12:75-80.
2. Ferrara A. Increasing prevalence of gestational diabetes mellitus: A public health perspective. Diabetes Care 2007;30 Suppl 2:S141-6.
3. International Association of Diabetes and Pregnancy Study Groups Consensus Panel; Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.
4. Basevi V, Di Mario S, Morciano C, Nonino F, Magrini N. Comment on: American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011;34:11-61.
5. Moses RG, Cheung NW. Point: Universal screening for gestational diabetes mellitus. Diabetes Care 2009;32:1349-51.
6. Mitanchez D. Foetal and neonatal complications in gestational diabetes: Perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications. Diabetes Med 2010;36:617-27.
7. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet 2009;373:1773-9.
8. Damm P. Future risk of diabetes in mother and child after gestational diabetes mellitus. Int J Gynecol Obstet 2009;104 Suppl 1:S25-6.
9. Nagalla SR, Canick JA, Jacob T, Schneider KA, Reddy AP, Thomas A, et al. Proteomic analysis of maternal serum in Down syndrome: Identification of novel protein biomarkers. J Proteome Res 2007;6:1245-57.
10. Balaji V, Balaji M, Anjalakshi C, Cynthia A, Arthi T, Seshiah V. Diagnosis of gestational diabetes mellitus in Asian-Indian women. Indian J Endocrinol Metab 2011;15:187-90.
11. Gravett MG, Thomas A, Schneider KA, Reddy AP, Dasari S, Jacob T, et al. Proteomic analysis of cervical-vaginal fluid: Identification of novel biomarkers for detection of intra-amniotic infection. J Proteome Res 2007;6:89-96.
12. Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G, et al. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007;30:629-37.
13. Pereira L, Reddy AP, Jacob T, Thomas A, Schneider KA, Dasari S, et al. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 2007;6:1269-76.
14. Rao PV, Reddy AP, Lu X, Dasari S, Krishnaprasad A, Biggs E, et al. Proteomic identification of salivary biomarkers of type 2 diabetes. J Proteome Res 2009;8:239-45.
15. Rasanen J, Girsen A, Lu X, Lapidus JA, Standley M, Reddy A, et al. Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia. J Proteome Res 2010;9:4274-81.
16. Hosmer DL, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley and Sons; 2001.
17. Thyfault JP, Hedberg EM, Anchan RM, Thorne OP, Isler CM, Newton ER, et al. Gestational diabetes is associated with depressed adiponectin levels. J Soc Gynecol Investig 2005;12:41-5.
18. Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 2011;31:135-41.
19. Vitoratos N, Valsamakis G, Mastorakos G, Boutsiadis A, Salakos N, Kouskouni E, et al. Pre? and early post-partum adiponectin and Interleukin-1beta levels in women with and without gestational diabetes. Hormones (Athens) 2008;7:230-6.
20. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes: A potential factor in progression to type 2 diabetes. Diabetes Care 2004;27:799-800.
21. Bartha JL, Comino-Delgado R, Romero-Carmona R, Gomez-Jaen MC. Sex hormone binding globulin in gestational diabetes. Acta Obstet Gynecol Scand 2000;79:839-45.
22. Thadhani R, Wolf M, Hsu-Blatman K, Sandler L, Nathan D, Ecker JL. First-trimester sex hormone binding globulinand subsequent gestational diabetes mellitus. Am J Obstet Gynecol 2003;189:171-6.
23. Morisset AS, Dubé MC, Drolet R, Robitaille J, Weisnagel SJ, Tchernof A. Sex hormone-binding globulin levels and obesity in women with gestational diabetes: Relationship with infant birth weight. Gynecol Endocrinol 2011;11:905-9.
24. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: The central role of maternal obesity. J Clin Endorinol Metabol 2003;88:3507-12.
25. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003;26:819-24.
26. Räty R, Anttila L, Virtanen A, Koskinen P, Laitinen P, Mörsky P, et al. Maternal midtrimester free beta-hCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy? induced hypertension or obstetric cholestasis. Prenat Diagn 2003;23:1045-8.
27. Olszewski J, Szczurowicz A, Wójcikowski C. Changes in levels of human placenta lactogen (hPL), progesterone, and estriol in blood serum and estrogens in urine during gestational diabetes mellitus. Ginekol Pol 1995;66:145-50.